Catecholaminergic polymorphic ventricular tachycardia classification
|
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
|
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Catecholaminergic polymorphic ventricular tachycardia classification On the Web |
|
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia classification |
|
FDA on Catecholaminergic polymorphic ventricular tachycardia classification |
|
CDC on Catecholaminergic polymorphic ventricular tachycardia classification |
|
Catecholaminergic polymorphic ventricular tachycardia classification in the news |
|
Blogs on Catecholaminergic polymorphic ventricular tachycardia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Catecholaminergic polymorphic ventricular tachycardia can be classified based upon the underlying pathogenic mutation.
Classification
CPVT may be classified based upon the underlying pathogenic mutation into the following subtypes:[1]
| Type | OMIM | Gene | Protein | Mode of inheritance | Locus |
|---|---|---|---|---|---|
| CPVT1 | 604772 | RyR2 | Ryanodine receptor 2 | Autosomal dominant | 1q42.1-q43 |
| CPVT2 | 611938 | CASQ2 | Calsequestrin 2 | Autosomal recessive | 1p13.3-p11 |
| CPVT3 | 614021 | Unknown | - | Autosomal recessive | 7p14–p22 |
| CPVT4 | 614916 | CALM1 | Calmodulin 1 | Autosomal dominant | 14q32.11 |
| CPVT5 | 615441 | TRDN | Triadin | Autosomal recessive | 6q22.31 |
References
- ↑ Sumitomo, Naokata (2016). "Current topics in catecholaminergic polymorphic ventricular tachycardia". Journal of Arrhythmia. 32 (5): 344–351. doi:10.1016/j.joa.2015.09.008. ISSN 1880-4276.